Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T19:46:57.338Z.
Calculation as of: 2026-10-06T19:46:57.338Z.
Quote observation: 2026-10-06T19:45:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6caa0376099c5ebdf209f9b018955c4d65987c3db8176dc1b5ff0a1c5aca19bf
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Bright Minds Biosciences Inc.
Market Cap
$474.58M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$477.04M
Price/FCF Ratio
N/A
TTM Avg
26.42
3Y Avg
26.42
5Y Avg
26.42
Market Cap
$468.55M
Price/FCF Ratio
N/A
TTM Avg
826.37
3Y Avg
710.39
5Y Avg
710.39
Market Cap
$484.31M
Price/FCF Ratio
11.79
TTM Avg
8.08
3Y Avg
11.34
5Y Avg
14.47
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bright Minds Biosciences Inc. (DRUG) | $474.58M | N/A | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $477.04M | N/A | 26.42 | 26.42 | 26.42 |
| Arvinas, Inc. (ARVN)vs › | $471.33M | N/A | 5.51 | 5.54 | 11.44 |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | N/A | N/A | N/A | N/A |
| Kamada Ltd. (KMDA)vs › | $468.77M | 17.70 | 24.31 | 87.97 | 67.12 |
| Cerus Corporation (CERS)vs › | $468.55M | N/A | 826.37 | 710.39 | 710.39 |
| Sight Sciences, Inc. (SGHT)vs › | $466.84M | N/A | N/A | N/A | N/A |
| Puma Biotechnology, Inc. (PBYI)vs › | $484.31M | 11.79 | 8.08 | 11.34 | 14.47 |
| Evolus, Inc. (EOLS)vs › | $486.34M | N/A | N/A | N/A | N/A |
| Oculis Holding AG (OCS)vs › | $491.66M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
